节点文献

两亲性壳聚糖衍生物在药物递送中的研究进展

Research progress on amphiphilic chitosan derivatives in drug delivery

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 田春莉鞠曹云张灿

【Author】 TIAN Chunli;JU Caoyun;ZHANG Can;Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Drug Discovery,China Pharmaceutical University;

【机构】 中国药科大学新药研究中心江苏省代谢性疾病重点实验室

【摘要】 壳聚糖是一种来源丰富的碱性多糖,具有良好的生物相容性和生物可降解性,但是其差的溶解性限制了壳聚糖在医药领域的应用。为了提高壳聚糖的溶解性,研究者对壳聚糖进行两亲性改性,通过选择不同的亲水、疏水基团,设计合成了两亲性壳聚糖衍生物。并利用其在水溶液中的自组装性能,形成两亲性壳聚糖纳米粒,用于多种药物的递送,以达到增加药物溶解性、稳定性、降低药物毒性和提高生物利用度等目的。本文综述了两亲性壳聚糖衍生物的合成方法,以及其在药物递送系统中的应用。

【Abstract】 Chitosan( CS) is a natural alkaline polysaccharide with a rich source,exhibiting good biocompatibility and biodegradability,but poor solubility limits its application in the field of medicine.In order to overcome its shortcomings,amphiphilic chemical modification of CS is carried out; by selecting different hydrophilic and hydrophobic groups,amphiphilic chitosan derivatives( ACSs) were designed and synthesized.ACSs are easily self-assembled into amphiphilic chitosan nanocarriers( ACNs) in water,which are widely used in the delivery of multiple drugs to increase drug solubility,stability,reduce drug toxicity,as well as improve bioavailability.In this work,the synthesis methods of ACSs and their applications in drug delivery systems were reviewed.

  • 【文献出处】 药学研究 ,Journal of Pharmaceutical Research , 编辑部邮箱 ,2018年09期
  • 【分类号】R943
  • 【被引频次】3
  • 【下载频次】597
节点文献中: 

本文链接的文献网络图示:

本文的引文网络